Company intelligence / Profile preview

D2G Oncology, Inc.

Palo Alto, California, United Statespitchbook.com ↗

Ownership: Private
Development stage: Preclinical

Overview

D2G Oncology is developing a platform to relate drugs to genotypes for precision cancer therapeutics. Their technology aims to increase the success rate of clinical trials and lead to more effective personalized cancer treatments

Therapeutic areas: Oncology
Modalities: Small molecules (drugs)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on D2G Oncology, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on D2G Oncology, Inc..

Explore the full profile